Skip to main content
Top
Published in: Malaria Journal 1/2021

Open Access 01-12-2021 | Malaria | Research

Household and individual level risk factors associated with declining malaria incidence in Meghalaya, India: implications for malaria elimination in low-endemic settings

Authors: Rajiv Sarkar, Anne Kessler, Bandapkupar Mawkhlieng, Steven A. Sullivan, Mark L. Wilson, Jane M. Carlton, Sandra Albert

Published in: Malaria Journal | Issue 1/2021

Login to get access

Abstract

Background

A detailed analysis of household and individual level Plasmodium infection patterns in two low-endemic districts of Meghalaya was undertaken to better understand the epidemiology of malaria in northeast India.

Methods

Socio-demographic and behavioural information from residents (aged 1–69 years) of households were collected through pre-tested, questionnaire conducted in 2018 and 2019. Blood samples collected from participants were tested for Plasmodium falciparum and/or Plasmodium vivax infection using rapid diagnostic test, microscopy and PCR. Plasma samples from a subset of participants were analysed for antibodies against thirteen P. falciparum and four P. vivax antigens. Associations between household and individual level risk factors, and Plasmodium infections were evaluated using multilevel logistic regression models.

Results

A total of 2753 individuals from 827 households were enrolled in 2018, and 834 individuals from 222 households were enrolled in 2019. Of them, 33 (1.2%) were positive by PCR for P. falciparum in 2018 and none were positive for P. vivax. In 2019, no PCR-positive individuals were detected. All, but one, infections were asymptomatic; all 33 infections were sub-microscopic. Reported history of malaria in the past 12 months (OR = 8.84) and history of travel in the past 14 days (OR = 10.06) were significantly associated with Plasmodium infection. A significant trend of increased seropositivity with age was noted for all 17 antigens. Although adults (≥ 18 years) consistently had the highest seropositivity rates, a sizeable proportion of under-five children were also found to be seropositive. Almost all individuals (99.4%) reported sleeping under an insecticide-treated bed-net, and household indoor residual spray coverage in the 12 months preceding the survey was low (23%). Most participants correctly identified common signs and symptoms of malaria, i.e., fever (96.4%), headache (71.2%), chills (83.2%) and body-ache (61.8%). Almost all participants (94.3%) used government-provided services for treatment of malaria.

Conclusion

This study explored the epidemiology of malaria in two communities in Meghalaya, India, in the context of declining transmission. The presence of widespread asymptomatic infections and seropositivity among under-five children suggest that low-level Plasmodium transmission persists in this region. Implications of the study findings for malaria elimination efforts in low-transmission settings are discussed.
Literature
1.
go back to reference WHO. World Malaria Report: 20 years of global progress and challenges. Geneva: World Health Organization; 2020. WHO. World Malaria Report: 20 years of global progress and challenges. Geneva: World Health Organization; 2020.
2.
go back to reference Guerin PJ, Dhorda M, Ganguly NK, Sibley CH. Malaria control in India: a national perspective in a regional and global fight to eliminate malaria. J Vector Borne Dis. 2019;56:41–5.PubMedCrossRef Guerin PJ, Dhorda M, Ganguly NK, Sibley CH. Malaria control in India: a national perspective in a regional and global fight to eliminate malaria. J Vector Borne Dis. 2019;56:41–5.PubMedCrossRef
3.
go back to reference Sarma DK, Mohapatra PK, Bhattacharyya DR, Chellappan S, Karuppusamy B, Barman K, et al. Malaria in North-East India: importance and implications in the era of elimination. Microorganisms. 2019;7:673.PubMedCentralCrossRef Sarma DK, Mohapatra PK, Bhattacharyya DR, Chellappan S, Karuppusamy B, Barman K, et al. Malaria in North-East India: importance and implications in the era of elimination. Microorganisms. 2019;7:673.PubMedCentralCrossRef
4.
go back to reference National Vector Borne Disease Control Programme (NVBDCP). National Framework for Malaria Elimination in India (2016–2030). 2016: Ministry of Health and Family Welfare, Government of India. National Vector Borne Disease Control Programme (NVBDCP). National Framework for Malaria Elimination in India (2016–2030). 2016: Ministry of Health and Family Welfare, Government of India.
5.
go back to reference National Vector Borne Disease Control Programme (NVBDCP). National Strategic Plan. Malaria Elimination in India. 2017–2022. New Delhi: Ministry of Health and Family Welfare. Government of India; 2017. National Vector Borne Disease Control Programme (NVBDCP). National Strategic Plan. Malaria Elimination in India. 2017–2022. New Delhi: Ministry of Health and Family Welfare. Government of India; 2017.
7.
8.
go back to reference Wangdi K, Gatton ML, Kelly GC, Banwell C, Dev V, Clements ACA. Malaria elimination in India and regional implications. Lancet Infect Dis. 2016;16:e214–24.PubMedCrossRef Wangdi K, Gatton ML, Kelly GC, Banwell C, Dev V, Clements ACA. Malaria elimination in India and regional implications. Lancet Infect Dis. 2016;16:e214–24.PubMedCrossRef
9.
go back to reference Dev V, Manguin S. Defeating malaria in the North-East region: the forerunner for malaria elimination in India. Acta Trop. 2021;222:106040.PubMedCrossRef Dev V, Manguin S. Defeating malaria in the North-East region: the forerunner for malaria elimination in India. Acta Trop. 2021;222:106040.PubMedCrossRef
10.
go back to reference Kessler A, van Eijk AM, Jamir L, Walton C, Carlton JM, Albert S. Malaria in Meghalaya: a systematic literature review and analysis of data from the National Vector-Borne Disease Control Programme. Malar J. 2018;17:411.PubMedPubMedCentralCrossRef Kessler A, van Eijk AM, Jamir L, Walton C, Carlton JM, Albert S. Malaria in Meghalaya: a systematic literature review and analysis of data from the National Vector-Borne Disease Control Programme. Malar J. 2018;17:411.PubMedPubMedCentralCrossRef
11.
go back to reference Kessler A, Shylla B, Singh US, Lyngdoh R, Mawkhlieng B, van Eijk AM, et al. Spatial and temporal village-level prevalence of Plasmodium infection and associated risk factors in two districts of Meghalaya. India Malar J. 2021;20:70.PubMedCrossRef Kessler A, Shylla B, Singh US, Lyngdoh R, Mawkhlieng B, van Eijk AM, et al. Spatial and temporal village-level prevalence of Plasmodium infection and associated risk factors in two districts of Meghalaya. India Malar J. 2021;20:70.PubMedCrossRef
14.
go back to reference Feroze SM, Raju VT, Singh R, Tripathi AK. Status of livestock sector: a micro study of North Eastern India. Ind J Hill Farming. 2010;23:43–51. Feroze SM, Raju VT, Singh R, Tripathi AK. Status of livestock sector: a micro study of North Eastern India. Ind J Hill Farming. 2010;23:43–51.
15.
go back to reference Demas A, Oberstaller J, DeBarry J, Lucchi NW, Srinivasamoorthy G, Sumari D, et al. Applied genomics: data mining reveals species-specific malaria diagnostic targets more sensitive than 18S rRNA. J Clin Microbiol. 2011;49:2411–8.PubMedPubMedCentralCrossRef Demas A, Oberstaller J, DeBarry J, Lucchi NW, Srinivasamoorthy G, Sumari D, et al. Applied genomics: data mining reveals species-specific malaria diagnostic targets more sensitive than 18S rRNA. J Clin Microbiol. 2011;49:2411–8.PubMedPubMedCentralCrossRef
16.
go back to reference Ompad DC, Kessler A, Van Eijk AM, Padhan TK, Haque MA, Sullivan SA, et al. The effectiveness of malaria camps as part of the Durgama Anchalare Malaria Nirakaran (DAMaN) program in Odisha, India: study protocol for a cluster-assigned quasi-experimental study. Glob Health Action. 2021;14:1886458.PubMedPubMedCentralCrossRef Ompad DC, Kessler A, Van Eijk AM, Padhan TK, Haque MA, Sullivan SA, et al. The effectiveness of malaria camps as part of the Durgama Anchalare Malaria Nirakaran (DAMaN) program in Odisha, India: study protocol for a cluster-assigned quasi-experimental study. Glob Health Action. 2021;14:1886458.PubMedPubMedCentralCrossRef
17.
go back to reference Wu L, Hall T, Ssewanyana I, Oulton T, Patterson C, Vasileva H, et al. Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology. Wellcome Open Res. 2019;4:26.PubMedCrossRef Wu L, Hall T, Ssewanyana I, Oulton T, Patterson C, Vasileva H, et al. Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology. Wellcome Open Res. 2019;4:26.PubMedCrossRef
18.
go back to reference Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.PubMedPubMedCentralCrossRef Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.PubMedPubMedCentralCrossRef
19.
go back to reference Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.CrossRef Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.CrossRef
20.
go back to reference Valliant R. A survey on survey statistics: what is done and can be done in stata. Stata J. 2007;7:1–21.CrossRef Valliant R. A survey on survey statistics: what is done and can be done in stata. Stata J. 2007;7:1–21.CrossRef
22.
go back to reference Kaura T, Kaur J, Sharma A, Dhiman A, Pangotra M, Upadhyay AK, et al. Prevalence of submicroscopic malaria in low transmission state of Punjab: a potential threat to malaria elimination. J Vector Borne Dis. 2019;56:78–84.PubMedCrossRef Kaura T, Kaur J, Sharma A, Dhiman A, Pangotra M, Upadhyay AK, et al. Prevalence of submicroscopic malaria in low transmission state of Punjab: a potential threat to malaria elimination. J Vector Borne Dis. 2019;56:78–84.PubMedCrossRef
23.
go back to reference Kumari P, Sinha S, Gahtori R, Yadav CP, Pradhan MM, Rahi M, et al. Prevalence of asymptomatic malaria parasitemia in Odisha, India: a challenge to malaria elimination. Am J Trop Med Hyg. 2020;103:1510–6.PubMedPubMedCentralCrossRef Kumari P, Sinha S, Gahtori R, Yadav CP, Pradhan MM, Rahi M, et al. Prevalence of asymptomatic malaria parasitemia in Odisha, India: a challenge to malaria elimination. Am J Trop Med Hyg. 2020;103:1510–6.PubMedPubMedCentralCrossRef
24.
go back to reference van Eijk AM, Sutton PL, Ramanathapuram L, Sullivan SA, Kanagaraj D, Priya GSL, et al. The burden of submicroscopic and asymptomatic malaria in India revealed from epidemiology studies at three varied transmission sites in India. Sci Rep. 2019;9:17095.PubMedPubMedCentralCrossRef van Eijk AM, Sutton PL, Ramanathapuram L, Sullivan SA, Kanagaraj D, Priya GSL, et al. The burden of submicroscopic and asymptomatic malaria in India revealed from epidemiology studies at three varied transmission sites in India. Sci Rep. 2019;9:17095.PubMedPubMedCentralCrossRef
25.
go back to reference Edwards HM, Dixon R, Zegers de Beyl C, Celhay O, Rahman M, Myint Oo M, et al. Prevalence and seroprevalence of Plasmodium infection in Myanmar reveals highly heterogeneous transmission and a large hidden reservoir of infection. PLoS ONE. 2021;16:e0252957.PubMedPubMedCentralCrossRef Edwards HM, Dixon R, Zegers de Beyl C, Celhay O, Rahman M, Myint Oo M, et al. Prevalence and seroprevalence of Plasmodium infection in Myanmar reveals highly heterogeneous transmission and a large hidden reservoir of infection. PLoS ONE. 2021;16:e0252957.PubMedPubMedCentralCrossRef
26.
go back to reference Motshoge T, Haiyambo DH, Ayanful-Torgby R, Aleksenko L, Ntebela D, Malleret B, et al. Recent molecular assessment of Plasmodium vivax and Plasmodium falciparum asymptomatic infections in Botswana. Am J Trop Med Hyg. 2021;104:2159–64.PubMedCentralCrossRef Motshoge T, Haiyambo DH, Ayanful-Torgby R, Aleksenko L, Ntebela D, Malleret B, et al. Recent molecular assessment of Plasmodium vivax and Plasmodium falciparum asymptomatic infections in Botswana. Am J Trop Med Hyg. 2021;104:2159–64.PubMedCentralCrossRef
27.
go back to reference Tadesse FG, Slater HC, Chali W, Teelen K, Lanke K, Belachew M, et al. The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia. Clin Infect Dis. 2018;66:1883–91.PubMedCrossRef Tadesse FG, Slater HC, Chali W, Teelen K, Lanke K, Belachew M, et al. The relative contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia. Clin Infect Dis. 2018;66:1883–91.PubMedCrossRef
28.
go back to reference Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.PubMedCrossRef Okell LC, Bousema T, Griffin JT, Ouedraogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.PubMedCrossRef
29.
go back to reference Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833–40.PubMedCrossRef Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol. 2014;12:833–40.PubMedCrossRef
30.
go back to reference Osier FH, Polley SD, Mwangi T, Lowe B, Conway DJ, Marsh K. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. Parasite Immunol. 2007;29:387–94.PubMedPubMedCentralCrossRef Osier FH, Polley SD, Mwangi T, Lowe B, Conway DJ, Marsh K. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3. Parasite Immunol. 2007;29:387–94.PubMedPubMedCentralCrossRef
31.
go back to reference Elliott SR, Fowkes FJ, Richards JS, Reiling L, Drew DR, Beeson JG. Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep. 2014;6:100.PubMedPubMedCentralCrossRef Elliott SR, Fowkes FJ, Richards JS, Reiling L, Drew DR, Beeson JG. Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep. 2014;6:100.PubMedPubMedCentralCrossRef
32.
go back to reference Idris ZM, Chan CW, Mohammed M, Kalkoa M, Taleo G, Junker K, et al. Serological measures to assess the efficacy of malaria control programme on Ambae Island. Vanuatu Parasit Vectors. 2017;10:204.PubMedCrossRef Idris ZM, Chan CW, Mohammed M, Kalkoa M, Taleo G, Junker K, et al. Serological measures to assess the efficacy of malaria control programme on Ambae Island. Vanuatu Parasit Vectors. 2017;10:204.PubMedCrossRef
33.
go back to reference Keffale M, Shumie G, Behaksra SW, Chali W, Hoogen L, Hailemeskel E, et al. Serological evidence for a decline in malaria transmission following major scale-up of control efforts in a setting selected for Plasmodium vivax and Plasmodium falciparum malaria elimination in Babile district, Oromia, Ethiopia. Trans R Soc Trop Med Hyg. 2019;113:305–11.PubMedPubMedCentralCrossRef Keffale M, Shumie G, Behaksra SW, Chali W, Hoogen L, Hailemeskel E, et al. Serological evidence for a decline in malaria transmission following major scale-up of control efforts in a setting selected for Plasmodium vivax and Plasmodium falciparum malaria elimination in Babile district, Oromia, Ethiopia. Trans R Soc Trop Med Hyg. 2019;113:305–11.PubMedPubMedCentralCrossRef
34.
go back to reference Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, et al. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS ONE. 2009;4:e6083.PubMedPubMedCentralCrossRef Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, et al. Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS ONE. 2009;4:e6083.PubMedPubMedCentralCrossRef
35.
go back to reference Zakeri S, van den Hoogen LL, Mehrizi AA, Karimi F, Raeisi A, Drakeley C. Anti-malarial seroprevalence assessment during an elimination programme in Chabahar District, south-eastern Iran. Malar J. 2016;15:382.PubMedPubMedCentralCrossRef Zakeri S, van den Hoogen LL, Mehrizi AA, Karimi F, Raeisi A, Drakeley C. Anti-malarial seroprevalence assessment during an elimination programme in Chabahar District, south-eastern Iran. Malar J. 2016;15:382.PubMedPubMedCentralCrossRef
36.
go back to reference Biggs J, Raman J, Cook J, Hlongwana K, Drakeley C, Morris N, et al. Serology reveals heterogeneity of Plasmodium falciparum transmission in northeastern South Africa: implications for malaria elimination. Malar J. 2017;16:48.PubMedPubMedCentralCrossRef Biggs J, Raman J, Cook J, Hlongwana K, Drakeley C, Morris N, et al. Serology reveals heterogeneity of Plasmodium falciparum transmission in northeastern South Africa: implications for malaria elimination. Malar J. 2017;16:48.PubMedPubMedCentralCrossRef
37.
go back to reference Liu Y, Sturrock HJW, Yang H, Gosling RD, Cao J. The challenge of imported malaria to eliminating countries. Lancet Infect Dis. 2017;17:141.PubMedCrossRef Liu Y, Sturrock HJW, Yang H, Gosling RD, Cao J. The challenge of imported malaria to eliminating countries. Lancet Infect Dis. 2017;17:141.PubMedCrossRef
38.
39.
go back to reference Kotepui M, Punsawad C, Kotepui KU, Somsak V, Phiwklam N, PhunPhuech B. Prevalence of malarial recurrence and hematological alteration following the initial drug regimen: a retrospective study in Western Thailand. BMC Public Health. 2019;19:1294.PubMedPubMedCentralCrossRef Kotepui M, Punsawad C, Kotepui KU, Somsak V, Phiwklam N, PhunPhuech B. Prevalence of malarial recurrence and hematological alteration following the initial drug regimen: a retrospective study in Western Thailand. BMC Public Health. 2019;19:1294.PubMedPubMedCentralCrossRef
40.
go back to reference Lawpoolsri S, Sattabongkot J, Sirichaisinthop J, Cui L, Kiattibutr K, Rachaphaew N, et al. Epidemiological profiles of recurrent malaria episodes in an endemic area along the Thailand-Myanmar border: a prospective cohort study. Malar J. 2019;18:124.PubMedPubMedCentralCrossRef Lawpoolsri S, Sattabongkot J, Sirichaisinthop J, Cui L, Kiattibutr K, Rachaphaew N, et al. Epidemiological profiles of recurrent malaria episodes in an endemic area along the Thailand-Myanmar border: a prospective cohort study. Malar J. 2019;18:124.PubMedPubMedCentralCrossRef
41.
go back to reference Rono J, Farnert A, Murungi L, Ojal J, Kamuyu G, Guleid F, et al. Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity. BMC Med. 2015;13:114.PubMedPubMedCentralCrossRef Rono J, Farnert A, Murungi L, Ojal J, Kamuyu G, Guleid F, et al. Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity. BMC Med. 2015;13:114.PubMedPubMedCentralCrossRef
42.
go back to reference Mwangi TW, Fegan G, Williams TN, Kinyanjui SM, Snow RW, Marsh K. Evidence for over-dispersion in the distribution of clinical malaria episodes in children. PLoS ONE. 2008;3:e2196.PubMedPubMedCentralCrossRef Mwangi TW, Fegan G, Williams TN, Kinyanjui SM, Snow RW, Marsh K. Evidence for over-dispersion in the distribution of clinical malaria episodes in children. PLoS ONE. 2008;3:e2196.PubMedPubMedCentralCrossRef
43.
go back to reference Smith DL, Dushoff J, Snow RW, Hay SI. The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature. 2005;438:492–5.PubMedPubMedCentralCrossRef Smith DL, Dushoff J, Snow RW, Hay SI. The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature. 2005;438:492–5.PubMedPubMedCentralCrossRef
44.
go back to reference Woolhouse ME, Dye C, Etard JF, Smith T, Charlwood JD, Garnett GP, et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci USA. 1997;94:338–42.PubMedPubMedCentralCrossRef Woolhouse ME, Dye C, Etard JF, Smith T, Charlwood JD, Garnett GP, et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci USA. 1997;94:338–42.PubMedPubMedCentralCrossRef
45.
go back to reference Clark TD, Greenhouse B, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Staedke SG, et al. Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda. J Infect Dis. 2008;198:393–400.PubMedCrossRef Clark TD, Greenhouse B, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Staedke SG, et al. Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda. J Infect Dis. 2008;198:393–400.PubMedCrossRef
46.
go back to reference Kreuels B, Kobbe R, Adjei S, Kreuzberg C, von Reden C, Bater K, et al. Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity. J Infect Dis. 2008;197:85–93.PubMedCrossRef Kreuels B, Kobbe R, Adjei S, Kreuzberg C, von Reden C, Bater K, et al. Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity. J Infect Dis. 2008;197:85–93.PubMedCrossRef
47.
go back to reference Goncalves BP, Kapulu MC, Sawa P, Guelbeogo WM, Tiono AB, Grignard L, et al. Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity. Nat Commun. 2017;8:1133.PubMedPubMedCentralCrossRef Goncalves BP, Kapulu MC, Sawa P, Guelbeogo WM, Tiono AB, Grignard L, et al. Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity. Nat Commun. 2017;8:1133.PubMedPubMedCentralCrossRef
48.
go back to reference Cooper L, Kang SY, Bisanzio D, Maxwell K, Rodriguez-Barraquer I, Greenhouse B, et al. Pareto rules for malaria super-spreaders and super-spreading. Nat Commun. 2019;10:3939.PubMedPubMedCentralCrossRef Cooper L, Kang SY, Bisanzio D, Maxwell K, Rodriguez-Barraquer I, Greenhouse B, et al. Pareto rules for malaria super-spreaders and super-spreading. Nat Commun. 2019;10:3939.PubMedPubMedCentralCrossRef
49.
go back to reference Pryce J, Richardson M, Lengeler C. Insecticide-treated nets for preventing malaria. Cochrane Database Syst Rev. 2018;11:CD000363.PubMed Pryce J, Richardson M, Lengeler C. Insecticide-treated nets for preventing malaria. Cochrane Database Syst Rev. 2018;11:CD000363.PubMed
50.
go back to reference Strode C, Donegan S, Garner P, Enayati AA, Hemingway J. The impact of pyrethroid resistance on the efficacy of insecticide-treated bed nets against African anopheline mosquitoes: systematic review and meta-analysis. PLoS Med. 2014;11:e1001619.PubMedPubMedCentralCrossRef Strode C, Donegan S, Garner P, Enayati AA, Hemingway J. The impact of pyrethroid resistance on the efficacy of insecticide-treated bed nets against African anopheline mosquitoes: systematic review and meta-analysis. PLoS Med. 2014;11:e1001619.PubMedPubMedCentralCrossRef
51.
go back to reference Shah MP, Steinhardt LC, Mwandama D, Mzilahowa T, Gimnig JE, Bauleni A, et al. The effectiveness of older insecticide-treated bed nets (ITNs) to prevent malaria infection in an area of moderate pyrethroid resistance: results from a cohort study in Malawi. Malar J. 2020;19:24.PubMedPubMedCentralCrossRef Shah MP, Steinhardt LC, Mwandama D, Mzilahowa T, Gimnig JE, Bauleni A, et al. The effectiveness of older insecticide-treated bed nets (ITNs) to prevent malaria infection in an area of moderate pyrethroid resistance: results from a cohort study in Malawi. Malar J. 2020;19:24.PubMedPubMedCentralCrossRef
52.
go back to reference WHO. Indoor residual spraying: an operational manual for indoor residual spraying (IRS) for malaria transmission control and elimination. 2nd ed. Geneva: World Health Organization; 2015. WHO. Indoor residual spraying: an operational manual for indoor residual spraying (IRS) for malaria transmission control and elimination. 2nd ed. Geneva: World Health Organization; 2015.
53.
go back to reference Prasad H. Evaluation of malaria control programme in three selected districts of Assam. India J Vector Borne Dis. 2009;46:280–7.PubMed Prasad H. Evaluation of malaria control programme in three selected districts of Assam. India J Vector Borne Dis. 2009;46:280–7.PubMed
54.
go back to reference Singh RK, Das MK, Dhiman RC, Mittal PK, Dua VK, Sreehari U, et al. Evaluation of indoor residual spray and insecticide treated bed nets in a malaria endemic area of Santhal Pargana, Dumka district (Jharkhand). J Commun Dis. 2012;44:169–79.PubMed Singh RK, Das MK, Dhiman RC, Mittal PK, Dua VK, Sreehari U, et al. Evaluation of indoor residual spray and insecticide treated bed nets in a malaria endemic area of Santhal Pargana, Dumka district (Jharkhand). J Commun Dis. 2012;44:169–79.PubMed
55.
go back to reference Tangena JA, Hendriks CMJ, Devine M, Tammaro M, Trett AE, Williams I, et al. Indoor residual spraying for malaria control in sub-Saharan Africa 1997 to 2017: an adjusted retrospective analysis. Malar J. 2020;19:150.PubMedPubMedCentralCrossRef Tangena JA, Hendriks CMJ, Devine M, Tammaro M, Trett AE, Williams I, et al. Indoor residual spraying for malaria control in sub-Saharan Africa 1997 to 2017: an adjusted retrospective analysis. Malar J. 2020;19:150.PubMedPubMedCentralCrossRef
56.
go back to reference Magaco A, Botao C, Nhassengo P, Saide M, Ubisse A, Chicumbe S, et al. Community knowledge and acceptance of indoor residual spraying for malaria prevention in Mozambique: a qualitative study. Malar J. 2019;18:27.PubMedPubMedCentralCrossRef Magaco A, Botao C, Nhassengo P, Saide M, Ubisse A, Chicumbe S, et al. Community knowledge and acceptance of indoor residual spraying for malaria prevention in Mozambique: a qualitative study. Malar J. 2019;18:27.PubMedPubMedCentralCrossRef
57.
go back to reference Suuron VM, Mwanri L, Tsourtos G, Owusu-Addo E. An exploratory study of the acceptability of indoor residual spraying for malaria control in upper western Ghana. BMC Public Health. 2020;20:465.PubMedPubMedCentralCrossRef Suuron VM, Mwanri L, Tsourtos G, Owusu-Addo E. An exploratory study of the acceptability of indoor residual spraying for malaria control in upper western Ghana. BMC Public Health. 2020;20:465.PubMedPubMedCentralCrossRef
58.
go back to reference Churcher TS, Lissenden N, Griffin JT, Worrall E, Ranson H. The impact of pyrethroid resistance on the efficacy and effectiveness of bednets for malaria control in Africa. Elife. 2016;5:e16090.PubMedPubMedCentralCrossRef Churcher TS, Lissenden N, Griffin JT, Worrall E, Ranson H. The impact of pyrethroid resistance on the efficacy and effectiveness of bednets for malaria control in Africa. Elife. 2016;5:e16090.PubMedPubMedCentralCrossRef
59.
go back to reference Hemingway J, Ranson H, Magill A, Kolaczinski J, Fornadel C, Gimnig J, et al. Averting a malaria disaster: will insecticide resistance derail malaria control? Lancet. 2016;387:1785–8.PubMedPubMedCentralCrossRef Hemingway J, Ranson H, Magill A, Kolaczinski J, Fornadel C, Gimnig J, et al. Averting a malaria disaster: will insecticide resistance derail malaria control? Lancet. 2016;387:1785–8.PubMedPubMedCentralCrossRef
60.
go back to reference Sherrard-Smith E, Griffin JT, Winskill P, Corbel V, Pennetier C, Djenontin A, et al. Systematic review of indoor residual spray efficacy and effectiveness against Plasmodium falciparum in Africa. Nat Commun. 2018;9:4982.PubMedPubMedCentralCrossRef Sherrard-Smith E, Griffin JT, Winskill P, Corbel V, Pennetier C, Djenontin A, et al. Systematic review of indoor residual spray efficacy and effectiveness against Plasmodium falciparum in Africa. Nat Commun. 2018;9:4982.PubMedPubMedCentralCrossRef
61.
go back to reference Rodriguez MH. Residual malaria: limitations of current vector control strategies to eliminate transmission in residual foci. J Infect Dis. 2021;223(Supplement_2):S55–S60.PubMedPubMedCentralCrossRef Rodriguez MH. Residual malaria: limitations of current vector control strategies to eliminate transmission in residual foci. J Infect Dis. 2021;223(Supplement_2):S55–S60.PubMedPubMedCentralCrossRef
62.
go back to reference Maslove DM, Mnyusiwalla A, Mills EJ, McGowan J, Attaran A, Wilson K. Barriers to the effective treatment and prevention of malaria in Africa: a systematic review of qualitative studies. BMC Int Health Hum Rights. 2009;9:26.PubMedPubMedCentralCrossRef Maslove DM, Mnyusiwalla A, Mills EJ, McGowan J, Attaran A, Wilson K. Barriers to the effective treatment and prevention of malaria in Africa: a systematic review of qualitative studies. BMC Int Health Hum Rights. 2009;9:26.PubMedPubMedCentralCrossRef
63.
go back to reference Bousema T, Youssef RM, Cook J, Cox J, Alegana VA, Amran J, et al. Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis. 2010;16:392–9.PubMedPubMedCentralCrossRef Bousema T, Youssef RM, Cook J, Cox J, Alegana VA, Amran J, et al. Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis. 2010;16:392–9.PubMedPubMedCentralCrossRef
64.
go back to reference Alemu K, Worku A, Berhane Y, Kumie A. Men traveling away from home are more likely to bring malaria into high altitude villages, northwest Ethiopia. PLoS ONE. 2014;9:e95341.PubMedPubMedCentralCrossRef Alemu K, Worku A, Berhane Y, Kumie A. Men traveling away from home are more likely to bring malaria into high altitude villages, northwest Ethiopia. PLoS ONE. 2014;9:e95341.PubMedPubMedCentralCrossRef
65.
go back to reference Saita S, Pan-Ngum W, Phuanukoonnon S, Sriwichai P, Silawan T, White LJ, et al. Human population movement and behavioural patterns in malaria hotspots on the Thai-Myanmar border: implications for malaria elimination. Malar J. 2019;18:64.PubMedPubMedCentralCrossRef Saita S, Pan-Ngum W, Phuanukoonnon S, Sriwichai P, Silawan T, White LJ, et al. Human population movement and behavioural patterns in malaria hotspots on the Thai-Myanmar border: implications for malaria elimination. Malar J. 2019;18:64.PubMedPubMedCentralCrossRef
66.
go back to reference Perraut R, Varela ML, Loucoubar C, Niass O, Sidibe A, Tall A, et al. Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities. PLoS ONE. 2017;12:e0179146.PubMedPubMedCentralCrossRef Perraut R, Varela ML, Loucoubar C, Niass O, Sidibe A, Tall A, et al. Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities. PLoS ONE. 2017;12:e0179146.PubMedPubMedCentralCrossRef
Metadata
Title
Household and individual level risk factors associated with declining malaria incidence in Meghalaya, India: implications for malaria elimination in low-endemic settings
Authors
Rajiv Sarkar
Anne Kessler
Bandapkupar Mawkhlieng
Steven A. Sullivan
Mark L. Wilson
Jane M. Carlton
Sandra Albert
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2021
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-021-03982-x

Other articles of this Issue 1/2021

Malaria Journal 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine